Senseonics Holdings (SENS) Tops Q4 EPS by 22c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Senseonics Holdings (SENS) Tops Q4 EPS by 22c, Offers Guidance

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

March 1, 2022 4:05 PM EST

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2021.

Recent Highlights & Accomplishments:

Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System, offering patients: Fully implantable third generation sensor, with proprietary sacrificial boronic acid (SBA) technology to enhance sensor longevity, demonstrating a mean... More